Acerus Pharmaceuticals Corporation

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Phase 4
Conditions
Interventions
First Posted Date
2021-07-26
Last Posted Date
2022-07-06
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
218
Registration Number
NCT04976595
Locations
🇺🇸

Eclipse Clinical Research, Tucson, Arizona, United States

🇺🇸

Preferred Research Partners, Little Rock, Arkansas, United States

🇺🇸

NYU Langone Health, New York, New York, United States

and more 27 locations

Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-10-19
Last Posted Date
2019-08-12
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
117
Registration Number
NCT02937740
Locations
🇨🇦

Clinique D'Andropause de Quebec, Quebec City, Quebec, Canada

🇨🇦

LMC Barrie, Barrie, Ontario, Canada

🇨🇦

Prostate Cancer Centre - Research, Calgary, Alberta, Canada

and more 8 locations

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

First Posted Date
2012-05-30
Last Posted Date
2018-08-13
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
253
Registration Number
NCT01607658
Locations
🇺🇸

Radiant Research Inc., San Antonio, Texas, United States

🇺🇸

Medical Center for Clinical Research, San Diego, California, United States

🇺🇸

San Diego Sexual Medicine, San Diego, California, United States

and more 44 locations

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-10-04
Last Posted Date
2018-06-13
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
306
Registration Number
NCT01446042
Locations
🇺🇸

Coastal Clinical Research, Mobile, Alabama, United States

🇺🇸

Diablo Clinical Reseach Inc., Walnut Creek, California, United States

🇺🇸

Capital Clinical Reseach Center, Olympia, Washington, United States

and more 27 locations

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

First Posted Date
2011-06-02
Last Posted Date
2019-10-16
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
24
Registration Number
NCT01364623
Locations
🇺🇸

Premier Research International LLC, Austin, Texas, United States

Efficacy of an Intranasal Testosterone Product

First Posted Date
2010-12-03
Last Posted Date
2018-05-23
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
22
Registration Number
NCT01252745
Locations
🇺🇸

Regional Urology LLC, Shreveport, Louisiana, United States

🇺🇸

Pharmax Research Clinic Inc., Miami, Florida, United States

🇺🇸

Quality of Life Medical and Research Center, Tucson, Arizona, United States

Efficacy and Tolerability of an Intra-Nasal Testosterone Product

First Posted Date
2009-09-11
Last Posted Date
2018-08-13
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
57
Registration Number
NCT00975650
Locations
🇺🇸

Regional Urology, LLC, Shreveport, Louisiana, United States

🇺🇸

Cetero Research, Miami Gardens, Florida, United States

🇺🇸

dgd Research Inc., San Antonio, Texas, United States

and more 3 locations

Influence of Administration Route of Testosterone on Male Fertility

Phase 1
Withdrawn
Conditions
Interventions
First Posted Date
2008-06-26
Last Posted Date
2018-03-13
Lead Sponsor
Acerus Pharmaceuticals Corporation
Registration Number
NCT00705796
Locations
🇳🇱

AMPHA, Nijmegen, Netherlands

NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-04-01
Last Posted Date
2018-03-30
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
32
Registration Number
NCT00647868
Locations
🇺🇸

Harbor - UCLA Medical Center, Torrance, California, United States

© Copyright 2024. All Rights Reserved by MedPath